Table 2

Hospital Characteristics by Hospital-Level Angiotensin Receptor/Neprilysin Inhibitor Prescription Rates

ARNI Prescription Ratep Value
0 (n = 125)>0 (n = 116)
Number of beds279 (203–425)345 (227–507)0.09
Teaching hospital76 (60.8%)67 (57.8%)0.63
Region0.006
 Northeast29 (23.2%)31 (26.7%)
 Midwest35 (28.0%)20 (17.2%)
 South33 (26.4%)51 (44.0%)
 West28 (22.4%)14 (12.1%)
Urban110 (88.0%)109 (94.0%)0.11
Heart transplantation performed5 (6.4%)10 (12.2%)0.21
Primary PCI performed75 (81.5%)85 (89.5%)0.12
Percentage Medicaid patients12.2 (6.5–21.7)11.8 (5.7–22.3)0.70

Values are median (interquartile range) or n (%). The table includes hospitals with 10 or more eligible hospitalizations during the study period. ARNI prescription rates among hospitals with any use: mean 7.3%, median 3.8% (interquartile range: 2.0% to 7.0%), minimum 0.13%, maximum 90.0%. Information for number of beds was available for 124 sites with no ARNI use and 113 sites with ARNI use. Information for heart transplantation was available for 78 sites with no ARNI use and 82 sites with ARNI use. Information for PCI was available for 92 sites with no ARNI use and 95 sites with ARNI use.

ARNI = angiotensin receptor/neprilysin inhibitor; PCI = percutaneous coronary intervention.